Beijing in 2016 required them to go through clinical trials … after raising HK$1 billion from an initial public offering in June. The IPO, under Hong Kong’s two year-old regime that allowed …
( read original story …)
Home BUSINESS Chinese biotech firm Immunotech deploys IPO cash to bet on next technology to fight liver cancer
ADVERTISEMENT
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- Citi to boost Japan, China investment banking teams, plans senior sector-focused hires 27/04/2026
- A Look At China Construction Bank’s Valuation As Regulatory Oversight Tightens On Chinese Banks 27/04/2026
- China taps another tool to drain excess cash from market 27/04/2026
- Beijing blocks Meta acquisition of Chinese AI startup Manus 27/04/2026
- China says it will reverse major AI acquisition by Meta 27/04/2026
- China bans Meta’s acquisition of Manus on national security grounds 27/04/2026
- China Orders the Unwinding of Meta’s Acquisition of an A.I. Start-Up 27/04/2026
- China blocks Meta’s acquisition of AI firm Manus 27/04/2026
- China industrial profits hit 6-month high amid Iran war as factory-gate prices rebound 27/04/2026
- Economists Rethink Chinese Forecasts as AI Fires Up Import Surge 27/04/2026
- China Pulled Deeper Into Iran As Trump Talks Stall 27/04/2026
- US government signals possible blockchain role in future drone security 27/04/2026